Literature DB >> 10794843

Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients.

B A Pappas1, P J Bayley, B K Bui, L A Hansen, L J Thal.   

Abstract

Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Item scores from the Mattis Dementia Rating Scale (MDRS) and the Mini-Mental State Examination (MMSE) from 389 patients with probable Alzheimer's disease were submitted to principal component analysis with orthogonal rotation. The optimal solution identified four factors that reflected the cognitive domains of attention/registration, verbal fluency/reasoning, graphomotor/praxis and recent memory. A subgroup of patients was identified for whom both the MDRS and the MMSE had been administered within the 12 months before death. Scores were assigned to these patients for the four factors. These cognitive-domain scores were then correlated with postmortem choline acetyltransferase (ChAT) activity in the medial frontal cortex, inferior parietal cortex, and hippocampus. ChAT activity in both the medial frontal and the inferior parietal cortex significantly correlated with scores on the graphomotor/praxis factor. Medial frontal ChAT also correlated significantly with the attention/registration scores. Hippocampal ChAT correlated significantly only with recent memory scores. These results are consistent with current animal research regarding the effect of selective cholinergic lesions on behavior.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794843     DOI: 10.1016/s0197-4580(00)00090-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  28 in total

1.  Phenotype-dependent susceptibility of cholinergic neuroblastoma cells to neurotoxic inputs.

Authors:  A Szutowicz; H Bielarczyk; S Gul; A Ronowska; T Pawełczyk; A Jankowska-Kulawy
Journal:  Metab Brain Dis       Date:  2006-05-25       Impact factor: 3.584

Review 2.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

Review 3.  Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?

Authors:  Karyn M Frick
Journal:  Horm Behav       Date:  2008-09-16       Impact factor: 3.587

4.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

5.  Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.

Authors:  Martin R Farlow; Stephen Salloway; Pierre N Tariot; Jane Yardley; Margaret L Moline; Qin Wang; Elimor Brand-Schieber; Heng Zou; Timothy Hsu; Andrew Satlin
Journal:  Clin Ther       Date:  2010-07       Impact factor: 3.393

6.  Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Angela L Guillozet-Bongaarts; Sarah M Ward; Bin He; Nicholas M Kanaan; Elliott J Mufson; Lester I Binder; Scott E Counts
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

7.  An exploration of cognitive subgroups in Alzheimer's disease.

Authors:  Julie E Davidson; Michael C Irizarry; Bethany C Bray; Sally Wetten; Nicholas Galwey; Rachel Gibson; Michael Borrie; Richard Delisle; Howard H Feldman; Ging-Yuek Hsiung; Luis Fornazzari; Serge Gauthier; Danilo Guzman; Inge Loy-English; Ron Keren; Andrew Kertesz; Peter St George-Hyslop; John Wherrett; Andreas U Monsch
Journal:  J Int Neuropsychol Soc       Date:  2009-12-04       Impact factor: 2.892

8.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Authors:  Michel Grothe; Laszlo Zaborszky; Mercedes Atienza; Eulogio Gil-Neciga; Rafael Rodriguez-Romero; Stefan J Teipel; Katrin Amunts; Aida Suarez-Gonzalez; Jose L Cantero
Journal:  Cereb Cortex       Date:  2009-11-04       Impact factor: 5.357

9.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

10.  Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease.

Authors:  Chelsea T Tiernan; Elliott J Mufson; Nicholas M Kanaan; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.